Education
About Us
Working with TipRanks
Follow Us
Amgen (IT:1AMGN)
:1AMGN
Total Valuation
Amgen has a market cap or net worth of $135.07B. The enterprise value is €190.17B.
Market Cap$135.07B
Enterprise Value€190.17B
Share Statistics
Amgen has 537,650,630 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding537,650,630
Owned by Insiders0.22%
Owned by Institutions0.03%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 8.91%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)8.91%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.19M
Profits Per Employee146.07K
Employee Count28,000
Asset Turnover0.36
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Amgen is 34.48. Amgen’s PEG ratio is -0.87.
PE Ratio34.48
PS Ratio0.00
PB Ratio23.99
Price to Fair Value23.99
Price to FCF13.57
Price to Operating Cash Flow12.27
PEG Ratio-0.87
Income Statement
In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.
Revenue33.42B
Gross Profit20.57B
Operating Income7.26B
Pretax Income4.61B
Net Income4.09B
EBITDA13.36B
Earnings Per Share (EPS)7.56
Cash Flow
In the last 12 months, operating cash flow was 11.49B and capital expenditures -1.10B, giving a free cash flow of 10.39B billion.
Operating Cash Flow11.49B
Free Cash Flow10.39B
Free Cash Flow per Share19.33
Dividends & Yields
Amgen pays an annual dividend of €8.083, resulting in a dividend yield of 3.14%
Dividend Per Share€8.083
Dividend Yield3.14%
Payout Ratio46.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.09
52-Week Price Change-1.73%
50-Day Moving Average267.66
200-Day Moving Average264.48
Relative Strength Index (RSI)45.46
Average Volume (3m)114.00
Important Dates
Amgen upcoming earnings date is Aug 5, 2025, TBA Not Confirmed.
Last Earnings DateMay 1, 2025
Next Earnings DateAug 5, 2025
Ex-Dividend DateMay 16, 2025
Financial Position
Amgen as a current ratio of 1.26, with Debt / Equity ratio of 1022.61%
Current Ratio1.26
Quick Ratio0.95
Debt to Market Cap0.43
Net Debt to EBITDA3.60
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Amgen has paid 519.00M in taxes.
Income Tax519.00M
Effective Tax Rate0.11
Enterprise Valuation
Amgen EV to EBITDA ratio is 14.16, with an EV/FCF ratio of 18.20.
EV to Sales5.66
EV to EBITDA14.16
EV to Free Cash Flow18.20
EV to Operating Cash Flow16.46
Balance Sheet
Amgen has $11.97B in cash and marketable securities with $9.29B in debt, giving a net cash position of $48.13B billion.
Cash & Marketable Securities$11.97B
Total Debt$9.29B
Net Cash$48.13B
Net Cash Per Share$89.51
Tangible Book Value Per Share-$74.78
Margins
Gross margin is 61.53%, with operating margin of 21.71%, and net profit margin of 12.24%.
Gross Margin61.53%
Operating Margin21.71%
Pretax Margin13.79%
Net Profit Margin12.24%
EBITDA Margin39.96%
EBIT Margin23.23%
Analyst Forecast
The average price target for Amgen is $289.12, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$289.12
Price Target Upside13.69% Upside
Analyst ConsensusModerate Buy
Analyst Count18
Revenue Growth Forecast―
EPS Growth Forecast―